Haemonetics
163 hedge funds and large institutions have $1.65B invested in Haemonetics in 2015 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 75 increasing their positions, 48 reducing their positions, and 27 closing their positions.
56% more repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 48
2% less capital invested
Capital invested by funds: $1.69B → $1.65B (-$34.9M)
1.55% less ownership
Funds ownership: 102.62% → 101.07% (-1.5%)
5% less funds holding
Funds holding: 171 → 163 (-8)
26% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 27
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$26.7M |
| 2 |
BCIM
Black Creek Investment Management
Toronto,
Ontario, Canada
|
+$17.9M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$12.2M |
| 4 |
Fuller & Thaler Asset Management
San Mateo,
California
|
+$11M |
| 5 |
WHG
Westwood Holdings Group
Dallas,
Texas
|
+$9.24M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Neuberger Berman Group
New York
|
-$43.1M |
| 2 |
Barrow, Hanley, Mewhinney & Strauss
Dallas,
Texas
|
-$12.8M |
| 3 |
RCAMU
Rothschild & Co Asset Management US
Stamford,
Connecticut
|
-$11.1M |
| 4 |
TAM
Tocqueville Asset Management
New York
|
-$8.71M |
| 5 |
PTC
Petrus Trust Company
Dallas,
Texas
|
-$8.24M |
HAE Hedge Fund Activity: Q4 2015 in Review
163 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Haemonetics (HAE) for Q4 2015, worth a combined $1.65B — down 2.1% from $1.69B a quarter earlier.
Sellers outnumbered buyers: 27 funds closed out of HAE and 20 opened new positions — a net loss of 7 holders — while 48 trimmed existing stakes and 75 added.
The largest buyer was T. Rowe Price Associates, adding an estimated $26.7M. The largest seller was Neuberger Berman Group, cutting an estimated $43.1M.
- 163 institutional investors held Haemonetics (HAE) as of Q4 2015, down from 171 in Q3 2015.
- Funds reported $1.65B of Haemonetics stock for Q4 2015, down 2.1% quarter-over-quarter.
- 20 funds opened new Haemonetics positions in Q4 2015 and 27 closed out, a net change of -7 holders.
- The largest Haemonetics buyer in Q4 2015 was T. Rowe Price Associates, an estimated $26.7M added.
- The largest Haemonetics seller in Q4 2015 was Neuberger Berman Group, an estimated $43.1M sold.
Based on aggregated 13F filings for Q4 2015.